Aureate Tradde IPO Day 2: GMP ₹0

Welcome back to our daily deep dive into the Aureate Tradde SME IPO on the BSE. As Day 2 of the subscription period (2026-05-29 to 2026-06-02) draws to a close, we’re seeing a familiar picture emerge. With the issue price fixed at ₹70 per share, the market is still taking its time to warm up to this offering. It’s still very early in the game, and we’ve got a couple more days for investors to make their decisions.

Subscription Status

Let’s break down the subscription numbers as they stand on Day 2. Currently, we have 0x subscription across all categories – Retail, NII (Non-Institutional Investors), and QIB (Qualified Institutional Buyers). That’s right, 0x for everyone. This might seem concerning at first glance, but for an SME IPO, especially on its second day, this isn’t entirely unexpected. It often takes until the last day, or at least the latter half of the subscription period, for significant traction to build. Retail investors, who typically form a large chunk of SME IPO subscriptions, might be waiting for more clarity or perhaps holding back to gauge the interest from other investor classes. The absence of NII and QIB interest so far is something to keep an eye on, though it’s too early to draw firm conclusions. Many institutional investors often make their decisions closer to the closing date.

GMP Update

Now, let’s talk Grey Market Premium (GMP). The current GMP for Aureate Tradde stands at ₹0. This is unchanged from yesterday’s reading. A GMP of ₹0 suggests that the market isn’t currently pricing in any premium over the issue price of ₹70. This aligns with the subdued subscription figures we’re seeing. Essentially, the market is expecting the stock to list at or around its issue price. While a ₹0 GMP isn’t a red flag in itself, especially for an SME IPO where GMPs can be volatile, it does indicate a lack of immediate speculative demand. Investors often look for a positive GMP as an indicator of potential listing gains. The fact that it has remained flat means no additional buying interest is being reflected in the unofficial market yet.

Should You Apply?

So, the big question: should you be applying for the Aureate Tradde IPO at this stage? Based on the data available on Day 2, it’s a mixed bag. The subscription numbers are non-existent, and the GMP is flat at ₹0, suggesting no immediate listing gains are expected by the market. However, it’s crucial to remember that this is an SME IPO, and the subscription dynamics can be quite different from mainboard issues. Many investors wait until the final day to subscribe, especially if they’re eyeing potential listing gains. The issue period runs until June 2nd, so there’s still time for things to change. As per SEBI’s advisory, investors should conduct thorough due diligence and understand the risks involved before investing. Don’t just rely on GMP or subscription numbers alone. Look at the company’s fundamentals, its business model, and its future prospects. If you’re looking for a conservative investment with no immediate listing gain expectations, and you believe in the company’s long-term potential, then perhaps it’s worth considering. However, if you’re primarily seeking quick listing gains, the current picture might not be very encouraging. Always remember to invest within your risk appetite.

View Full Aureate Tradde IPO Details